ResearcherEssen University HospitalActive in the last 2 years
Johannes Notni
Matched on ORCID iD 0000-0002-3964-3391; OpenAlex author ID A5002482582. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 9
2022: 1 paper · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 4
- Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting 68Ga / 177Lu labeled theranostic pair. Co-author DOI 10.1007/s00259-025-07701-5↗
- Concomitant metastatic head-and-neck cancer and pancreatic cancer assessed by αvβ6-integrin PET/CT using 68Ga-Trivehexin: incidental detection of a brain metas… Co-author DOI 10.1007/s00259-024-06750-6↗
- αvβ6-integrin targeted PET/CT imaging in pancreatic cancer patients using 68Ga-Trivehexin. Co-author DOI 10.3389/fnume.2024.1487602↗
- PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Trivehexin. Last author DOI 10.1007/s00259-021-05559-x↗
Closest collaborators
The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jörg Kotzerke · 3 shared papers, 2022–2024 · strength 0.60
- Paper Concomitant metastatic head-and-neck cancer and pancreatic cancer assessed by αvβ6-integrin PET/CT using 68Ga-Trivehexi… DOI 10.1007/s00259-024-06750-6↗
- Paper αvβ6-integrin targeted PET/CT imaging in pancreatic cancer patients using 68Ga-Trivehexin. DOI 10.3389/fnume.2024.1487602↗
- Paper PET/CT imaging of head-and-neck and pancreatic cancer in humans by targeting the "Cancer Integrin" αvβ6 with Ga-68-Triv… DOI 10.1007/s00259-021-05559-x↗
- Sebastian Hempel · 2 shared papers, 2024 · strength 0.46
- Jana Rehm · 2 shared papers, 2024 · strength 0.46
- Marius Distler · 2 shared papers, 2024 · strength 0.46
- Michael Christoph Kreissl · 1 shared paper, 2026 · strength 0.29
- Akram Al‐Ibraheem · 1 shared paper, 2026 · strength 0.29
- Jan Wuestemann · 1 shared paper, 2026 · strength 0.29
- Neil Gerard Quigley · 1 shared paper, 2022 · strength 0.14
- Wilko Weichert · 1 shared paper, 2022 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.